- Home
- QURE vs PAMT Comparison
QURE vs PAMT Comparison
Compare QURE & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- PAMT
- Stock Information
- Founded
- QURE 1998
- PAMT 1980
- Country
- QURE Netherlands
- PAMT United States
- Employees
- QURE N/A
- PAMT N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- PAMT Trucking Freight/Courier Services
- Sector
- QURE Health Care
- PAMT Industrials
- Exchange
- QURE Nasdaq
- PAMT Nasdaq
- Market Cap
- QURE 432.6M
- PAMT 414.1M
- IPO Year
- QURE 2007
- PAMT 1985
- Fundamental
- Price
- QURE $5.85
- PAMT $17.92
- Analyst Decision
- QURE Buy
- PAMT
- Analyst Count
- QURE 6
- PAMT 0
- Target Price
- QURE $17.00
- PAMT N/A
- AVG Volume (30 Days)
- QURE 792.5K
- PAMT 28.9K
- Earning Date
- QURE 11-05-2024
- PAMT 10-24-2024
- Dividend Yield
- QURE N/A
- PAMT N/A
- EPS Growth
- QURE N/A
- PAMT N/A
- EPS
- QURE N/A
- PAMT N/A
- Revenue
- QURE $28,587,000.00
- PAMT $728,284,000.00
- Revenue This Year
- QURE $157.96
- PAMT N/A
- Revenue Next Year
- QURE N/A
- PAMT N/A
- P/E Ratio
- QURE N/A
- PAMT N/A
- Revenue Growth
- QURE N/A
- PAMT N/A
- 52 Week Low
- QURE $3.73
- PAMT $13.51
- 52 Week High
- QURE $11.35
- PAMT $23.70
- Technical
- Relative Strength Index (RSI)
- QURE 43.86
- PAMT N/A
- Support Level
- QURE $5.50
- PAMT N/A
- Resistance Level
- QURE $7.96
- PAMT N/A
- Average True Range (ATR)
- QURE 0.59
- PAMT 0.00
- MACD
- QURE -0.16
- PAMT 0.00
- Stochastic Oscillator
- QURE 18.97
- PAMT 0.00
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.